These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 36989005)
21. Activity of ceftaroline against extracellular (broth) and intracellular (THP-1 monocytes) forms of methicillin-resistant Staphylococcus aureus: comparison with vancomycin, linezolid and daptomycin. Mélard A; Garcia LG; Das D; Rozenberg R; Tulkens PM; Van Bambeke F; Lemaire S J Antimicrob Chemother; 2013 Mar; 68(3):648-58. PubMed ID: 23188792 [TBL] [Abstract][Full Text] [Related]
22. Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011. Sader HS; Flamm RK; Jones RN Antimicrob Agents Chemother; 2013 Jul; 57(7):3178-81. PubMed ID: 23629712 [TBL] [Abstract][Full Text] [Related]
23. Combination Therapy With Vancomycin and Ceftaroline for Refractory Methicillin-resistant Staphylococcus aureus Bacteremia: A Case Series. Gritsenko D; Fedorenko M; Ruhe JJ; Altshuler J Clin Ther; 2017 Jan; 39(1):212-218. PubMed ID: 28038791 [TBL] [Abstract][Full Text] [Related]
24. Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care. Johnson TM; Molina KC; Miller MA; Kiser TH; Huang M; Mueller SW Int J Antimicrob Agents; 2021 Apr; 57(4):106310. PubMed ID: 33609718 [TBL] [Abstract][Full Text] [Related]
25. A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA). Shafiq I; Bulman ZP; Spitznogle SL; Osorio JE; Reilly IS; Lesse AJ; Parameswaran GI; Mergenhagen KA; Tsuji BT Infect Dis (Lond); 2017 May; 49(5):410-416. PubMed ID: 28116950 [TBL] [Abstract][Full Text] [Related]
26. Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant Yi YH; Wang JL; Yin WJ; Xu WH Microb Drug Resist; 2021 Aug; 27(8):1044-1056. PubMed ID: 33728980 [No Abstract] [Full Text] [Related]
27. Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model. Werth BJ; Sakoulas G; Rose WE; Pogliano J; Tewhey R; Rybak MJ Antimicrob Agents Chemother; 2013 Jan; 57(1):66-73. PubMed ID: 23070161 [TBL] [Abstract][Full Text] [Related]
28. Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant Zasowski EJ; Trinh TD; Claeys KC; Lagnf AM; Bhatia S; Klinker KP; Veve MP; Estrada SJ; Johns ST; Sawyer AJ; Huang V; LaFrance B; Levine DP; Kaye KS; Davis SL; Rybak MJ Open Forum Infect Dis; 2022 Mar; 9(3):ofab606. PubMed ID: 35146040 [TBL] [Abstract][Full Text] [Related]
29. Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report. Duss FR; Garcia de la Mària C; Croxatto A; Giulieri S; Lamoth F; Manuel O; Miró JM J Antimicrob Chemother; 2019 Sep; 74(9):2626-2630. PubMed ID: 31298264 [TBL] [Abstract][Full Text] [Related]
30. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches. Holubar M; Meng L; Deresinski S Infect Dis Clin North Am; 2016 Jun; 30(2):491-507. PubMed ID: 27208769 [TBL] [Abstract][Full Text] [Related]
31. Adjunctive ceftaroline in combination with daptomycin or vancomycin for complicated methicillin-resistant Hornak JP; Anjum S; Reynoso D Ther Adv Infect Dis; 2019; 6():2049936119886504. PubMed ID: 31857898 [TBL] [Abstract][Full Text] [Related]
32. Physiologically based pharmacokinetic modelling to inform combination dosing regimens of ceftaroline and daptomycin in special populations. Martins FS; Martins JES; Severino P; Annaert P; Sy SKB Br J Clin Pharmacol; 2023 Sep; 89(9):2726-2738. PubMed ID: 37005335 [TBL] [Abstract][Full Text] [Related]
35. Methicillin-resistant Staphylococcus aureus epidural abscess treated with ceftaroline fosamil salvage therapy. Bucheit J; Collins R; Joshi P Am J Health Syst Pharm; 2014 Jan; 71(2):110-3. PubMed ID: 24375602 [TBL] [Abstract][Full Text] [Related]
36. Using an Ordinal Approach to Compare Outcomes Between Vancomycin Versus Ceftaroline or Daptomycin in MRSA Bloodstream Infection. Barlow A; Heil EL; Claeys KC Infect Dis Ther; 2021 Mar; 10(1):605-612. PubMed ID: 33484408 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of the synergistic effect of ceftaroline against methicillin-resistant Staphylococcus aureus. Tsai CE; Yang CJ; Chuang YC; Wang JT; Sheng WH; Chen YC; Chang SC Int J Infect Dis; 2022 Sep; 122():230-236. PubMed ID: 35640827 [TBL] [Abstract][Full Text] [Related]
38. Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy. Ho TT; Cadena J; Childs LM; Gonzalez-Velez M; Lewis JS J Antimicrob Chemother; 2012 May; 67(5):1267-70. PubMed ID: 22311935 [TBL] [Abstract][Full Text] [Related]
39. In vitro pharmacodynamics of human simulated exposures of ceftaroline and daptomycin against MRSA, hVISA, and VISA with and without prior vancomycin exposure. Bhalodi AA; Hagihara M; Nicolau DP; Kuti JL Antimicrob Agents Chemother; 2014; 58(2):672-7. PubMed ID: 24217694 [TBL] [Abstract][Full Text] [Related]
40. In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections. Isnard C; Dhalluin A; Malandain D; Bruey Q; Auzou M; Michon J; Giard JC; Guérin F; Cattoir V J Glob Antimicrob Resist; 2018 Jun; 13():221-225. PubMed ID: 29421316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]